Académique Documents
Professionnel Documents
Culture Documents
Why
Valuation ?
Test impairment IPO/FPO
Value of
Value of the - debt (less = Value of
operational cash) Equity
business i.e
Enterprise Bondholder value
Value
Shareholder value
Enterprise value
(Value of Business)
EV & Balance Sheet - a
comprehensive picture
Cash + Debt (MV)
Financial Preference
Cash
Invest-
equivalents - Shares
Ments, Invt
in associates + Minority
Non interest
controlled
Investment =
s+
Land Non-core Ordinary Equity
banks assets + value
Enterprise
value (net
operating
assets: EV)
Valuation
Methods
DDM
Debtholders
Preferred stockholders
FCFF vs. FCFE Approaches to
Equity Valuation
Equity Value
FCFEt
Equity value
t 1 1 r
t
Single-Stage Free Cash Flow
Models
FCFF1
Firm value
WACC g
Equity value Firm value Debt value
FCFE1
Equity value
rg
Example: Single-Stage FCFF
Model
Current FCFF $6,000,000
Target debt to capital 0.25
Market value of debt $30,000,000
Shares outstanding 2,900,000
Required return on equity 12%
Cost of debt 7%
Long-term growth in FCFF 5%
Tax rate 30%
Example: Single-Stage FCFF
Model
MV(Debt) MV(Equity)
WACC
d r (1 Tax rate)
r
MV(Equity) MV(Debt) MV(Equity) MV(Debt)
FCFF1
Firm value
WACC g
$6, 000, 000(1.05)
Firm value $120.5 million
0.0123 0.05
Equity value $120.5 million $30 million $90.5 million
Equity value per share $90.5 million 2.9 million $31.21
Using Net Income to Determine
FCFF
EBITDA $1,000
Depreciation expense $400
Interest expense $150
Tax rate 30%
Purchases of fixed assets $500
Change in working capital $50
Net borrowing $80
Common dividends $200
Example: Calculating FCFF from
Net Income
NI EBITDA – Dep – Int 1 – Tax rate
$800 $700
Incremental FC/Sales growth 50%
$200
$50
Incremental WC/Sales growth 25%
$200
Example: Forecasting FCFF
Sales $200 $4000 $4200
EBIT $4200 × 15% $630
EBIT(1 ax rate) $630 × (1 30%) $441
Incremental FC $200 50% $100
Incremental WC $200 25% $50
FCFF EBIT(1 Tax rate) ΔCapital expenditures ΔWCInv
FCFF $441 $100 $50 $291
Example: Forecasting FCFE
Sales $200 $4000 $4200
Net income $4200 10% $420
Incremental FC $200 50% $100
Incremental WC $200 25% $50
Country Adjustments
Sensitivity Analysis
Nonoperating Assets
Simple Two-Stage FCF Models
n
FCFFt FCFFn 1
Firm value
1
+
t 1 1 WACC t
WACC g (1 WACC) n
n
FCFEt FCFEn 1
1
Equity value +
t =1 1 r
t
r g (1 r )n
Illustration
Example: Three-Stage FCF
Models
Current FCFF in millions $100 .00
Year
1 2 3 4 5 6
FCFFn 1 1
Terminal value
WACC g (1 WACC)n
$320.4 1
Terminal value $3979
0.10 0.05 (1 0.10) 5
Example: Three-Stage FCF
Models
n
FCFFt FCFFn 1
1
Firm value +
t =1 1 WACC t
WACC g (1 WACC)n
• EBIT
Earnings
• EBITDA
Enterprise
value or • Sales
Price of Revenue
• Sales growth
equity
• Employees
Non • Production
Financial quantity etc.
Most popular multiples
Price earnings (PE) : Ratio of price per
share and earnings per share.
Price to book value (PBV): ratio of price
per share to book value per share
Price to Sales(PS): ratio of price per share
to sales value per share.
By replacing price by enterprise value we
can get 3 more ratios, where
EV = Market value of equity + market
value of debt - cash
Understanding the multiples
Define – understand its calculation
Describe – cross section distribution
Analyse – drivers of the multiples
Apply – easily said than done
Understanding multiples – an example
Mean multiples of the pharmaceutical sector for the period 200503-201003
PE, EV_PBIT AND EV_PBITDA fall within a range of 13-25 for the sector.
However, PBV, Mcap_sales and EV_sales are distributed in a range of
3.25-4.97. In the last four quarters from 2009-03 to 2010-03 the entire
sectors mean multiples have shown consistently increasing trend
Steps in relative valuation
• Arrive at comparable companies
Peer Group • (Size, nature, growth, margin, risk)
BSE_Close Mcap_sale
Company Name YYYYMM _Price PE PBV s EV_sales EV_PBIDT EV_PBIT
Abbott India Ltd 201002 904.4 16.44 4.56 1.51 1.51 10.10 10.92
Astrazeneca Pharma India
201003Ltd 860.6 40.63 14.89 5.20 5.20 24.89 26.74
Lupin Ltd 201003 324.91 21.51 5.71 3.97 4.22 18.76 21.67
Merck Ltd 201003 621.95 14.33 2.21 2.15 2.15 9.14 9.80
Median 18.97 5.13 3.06 3.18 14.43 16.30
Mean 23.23 6.84 3.20 3.27 15.72 17.28
harmonic 19.83 4.37 2.54 2.57 13.25 14.43
Relative valuation - projections
BSE_Close_P
Company Name YYYYMM rice actual Yearly_EPS BookValue Sales PBIDT PBIT
Lupin Ltd 201103 415.35 18.158 70.6558 4420.86 975.6 845.63